Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Leslie B. Poole, Ph.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentStructural Biology
Address
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    F32GM013211     (POOLE, LESLIE B)Nov 30, 1989
    NIH/NIGMS
    REVERSION MUTAGENESIS OF ACTIVE-SITE MUTANTS OF NUCLEASE
    Role: Principal Investigator

    R01GM050389     (POOLE, LESLIE B)Dec 1, 1993 - Apr 30, 2014
    NIH/NIGMS
    Mechanistic Studies of Alkyl Hydroperoxide Reductase and Related Redox Proteins
    Role: Principal Investigator

    R21CA112145     (POOLE, LESLIE B)May 1, 2005 - Oct 31, 2008
    NIH/NCI
    Profiling of Redox-Sensitive Signaling Proteins
    Role: Principal Investigator

    R33CA126659     (POOLE, LESLIE B)May 1, 2008 - Apr 30, 2012
    NIH/NCI
    Proteomic Profiling of Cancer-Related Redox Signaling Pathways
    Role: Principal Investigator

    R13CA144356     (POOLE, LESLIE B)May 1, 2010 - Apr 30, 2011
    NIH/NCI
    2010 Thiol-based Redox Regulation &Signaling Gordon Research Conference
    Role: Principal Investigator

    T32GM095440     (POOLE, LESLIE B)Jul 1, 2011 - Jun 30, 2021
    NIH/NIGMS
    Structural and Computational Biophysics Training Program
    Role: Principal Investigator

    R13ES021119     (POOLE, LESLIE B)Sep 22, 2011 - Aug 31, 2012
    NIH/NIEHS
    2012 Thiol-based Redox Regulation &Signaling GRC and GRS
    Role: Principal Investigator

    R33CA177461     (FURDUI, CRISTINA MARIA)Sep 1, 2013 - Aug 31, 2016
    NIH/NCI
    New Reagents for Tracking Protein Oxidation in Cells by MS and Imaging Methods
    Role: Co-Principal Investigator

    R01GM119227     (POOLE, LESLIE B)Apr 5, 2016 - Mar 31, 2020
    NIH/NIGMS
    Mechanisms and Regulation of Peroxiredoxins
    Role: Principal Investigator

    T32GM127261     (POOLE, LESLIE B)Jul 1, 2018 - Jun 30, 2022
    NIH/NIGMS
    Redox Biology and Medicine Training Program
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Al-Barakati HJ, McConnell EW, Hicks LM, Poole LB, Newman RH, Kc DB. SVM-SulfoSite: A support vector machine based predictor for sulfenylation sites. Sci Rep. 2018 Jul 26; 8(1):11288. PMID: 30050050.
      View in: PubMed
    2. Bolduc JA, Nelson KJ, Haynes AC, Lee J, Reisz JA, Graff AH, Clodfelter JE, Parsonage D, Poole LB, Furdui CM, Lowther WT. Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins. J Biol Chem. 2018 07 27; 293(30):11901-11912. PMID: 29884768.
      View in: PubMed
    3. Holmila RJ, Vance SA, Chen X, Wu H, Shukla K, Bharadwaj MS, Mims J, Wary Z, Marrs G, Singh R, Molina AJ, Poole LB, King SB, Furdui CM. Mitochondria-targeted Probes for Imaging Protein Sulfenylation. Sci Rep. 2018 Apr 27; 8(1):6635. PMID: 29703899.
      View in: PubMed
    4. Portillo-Ledesma S, Randall LM, Parsonage D, Dalla Rizza J, Karplus PA, Poole LB, Denicola A, Ferrer-Sueta G. Differential Kinetics of Two-Cysteine Peroxiredoxin Disulfide Formation Reveal a Novel Model for Peroxide Sensing. Biochemistry. 2018 06 19; 57(24):3416-3424. PMID: 29553725.
      View in: PubMed
    5. Long D, Wu H, Tsang AW, Poole LB, Yoza BK, Wang X, Vachharajani V, Furdui CM, McCall CE. The Oxidative State of Cysteine Thiol 144 Regulates the SIRT6 Glucose Homeostat. Sci Rep. 2017 09 08; 7(1):11005. PMID: 28887543.
      View in: PubMed
    6. Keyes JD, Parsonage D, Yammani RD, Rogers LC, Kesty C, Furdui CM, Nelson KJ, Poole LB. Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals. Free Radic Biol Med. 2017 11; 112:534-543. PMID: 28843779.
      View in: PubMed
    7. Chen X, Wu H, Park CM, Poole TH, Keceli G, Devarie-Baez NO, Tsang AW, Lowther WT, Poole LB, King SB, Xian M, Furdui CM. Discovery of Heteroaromatic Sulfones As a New Class of Biologically Compatible Thiol-Selective Reagents. ACS Chem Biol. 2017 08 18; 12(8):2201-2208. PMID: 28687042.
      View in: PubMed
    8. Mauney CH, Rogers LC, Harris RS, Daniel LW, Devarie-Baez NO, Wu H, Furdui CM, Poole LB, Perrino FW, Hollis T. The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch. Antioxid Redox Signal. 2017 Dec 01; 27(16):1317-1331. PMID: 28398823.
      View in: PubMed
    9. Nelson KJ, Perkins A, Van Swearingen AED, Hartman S, Brereton AE, Parsonage D, Salsbury FR, Karplus PA, Poole LB. Experimentally Dissecting the Origins of Peroxiredoxin Catalysis. Antioxid Redox Signal. 2018 Mar 01; 28(7):521-536. PMID: 28375740.
      View in: PubMed
    10. Perkins A, Parsonage D, Nelson KJ, Ogba OM, Cheong PH, Poole LB, Karplus PA. Peroxiredoxin Catalysis at Atomic Resolution. Structure. 2016 Oct 04; 24(10):1668-1678. PMID: 27594682.
      View in: PubMed
    11. Wood ST, Long DL, Reisz JA, Yammani RR, Burke EA, Klomsiri C, Poole LB, Furdui CM, Loeser RF. Cysteine-Mediated Redox Regulation of Cell Signaling in Chondrocytes Stimulated With Fibronectin Fragments. Arthritis Rheumatol. 2016 Jan; 68(1):117-26. PMID: 26314228.
      View in: PubMed
    12. Randall L, Manta B, Nelson KJ, Santos J, Poole LB, Denicola A. Structural changes upon peroxynitrite-mediated nitration of peroxiredoxin 2; nitrated Prx2 resembles its disulfide-oxidized form. Arch Biochem Biophys. 2016 Jan 15; 590:101-108. PMID: 26612102.
      View in: PubMed
    13. Buchko GW, Perkins A, Parsonage D, Poole LB, Karplus PA. Backbone chemical shift assignments for Xanthomonas campestris peroxiredoxin Q in the reduced and oxidized states: a dramatic change in backbone dynamics. Biomol NMR Assign. 2016 Apr; 10(1):57-61. PMID: 26438558.
      View in: PubMed
    14. Vera T, D'Agostino RB, Jordan JH, Whitlock MC, Meléndez GC, Lamar ZS, Porosnicu M, Bonkovsky HL, Poole LB, Hundley WG. Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy. Am J Cardiol. 2015 Dec 01; 116(11):1752-5. PMID: 26433273.
      View in: PubMed
    15. Langston PK, Yang M, Bierbach U, Parsonage D, Poole LB, Price MJ, Grayson JM. Au-ACRAMTU-PEt3 Alters Redox Balance To Inhibit T Cell Proliferation and Function. J Immunol. 2015 Sep 01; 195(5):1984-94. PMID: 26209624.
      View in: PubMed
    16. Perkins A, Nelson KJ, Parsonage D, Poole LB, Karplus PA. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 2015 Aug; 40(8):435-45. PMID: 26067716.
      View in: PubMed
    17. Poole LB, Schöneich C. Introduction: What we do and do not know regarding redox processes of thiols in signaling pathways. Free Radic Biol Med. 2015 Mar; 80:145-7. PMID: 25746478.
      View in: PubMed
    18. Parsonage D, Nelson KJ, Ferrer-Sueta G, Alley S, Karplus PA, Furdui CM, Poole LB. Dissecting peroxiredoxin catalysis: separating binding, peroxidation, and resolution for a bacterial AhpC. Biochemistry. 2015 Feb 24; 54(7):1567-75. PMID: 25633283.
      View in: PubMed
    19. Perkins A, Poole LB, Karplus PA. Tuning of peroxiredoxin catalysis for various physiological roles. Biochemistry. 2014 Dec 16; 53(49):7693-705. PMID: 25403613.
      View in: PubMed
    20. Poole LB. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med. 2015 Mar; 80:148-57. PMID: 25433365.
      View in: PubMed
    21. Poole TH, Reisz JA, Zhao W, Poole LB, Furdui CM, King SB. Strained cycloalkynes as new protein sulfenic acid traps. J Am Chem Soc. 2014 Apr 30; 136(17):6167-70. PMID: 24724926.
      View in: PubMed
    22. Randall LM, Manta B, Hugo M, Gil M, Batthyàny C, Trujillo M, Poole LB, Denicola A. Nitration transforms a sensitive peroxiredoxin 2 into a more active and robust peroxidase. J Biol Chem. 2014 May 30; 289(22):15536-43. PMID: 24719319.
      View in: PubMed
    23. Klomsiri C, Rogers LC, Soito L, McCauley AK, King SB, Nelson KJ, Poole LB, Daniel LW. Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling. Free Radic Biol Med. 2014 Jun; 71:49-60. PMID: 24657741.
      View in: PubMed
    24. Perkins A, Nelson KJ, Williams JR, Parsonage D, Poole LB, Karplus PA. The sensitive balance between the fully folded and locally unfolded conformations of a model peroxiredoxin. Biochemistry. 2013 Dec 03; 52(48):8708-21. PMID: 24175952.
      View in: PubMed
    25. Reisz JA, Bechtold E, King SB, Poole LB, Furdui CM. Thiol-blocking electrophiles interfere with labeling and detection of protein sulfenic acids. FEBS J. 2013 Dec; 280(23):6150-61. PMID: 24103186.
      View in: PubMed
    26. Furdui CM, Poole LB. Chemical approaches to detect and analyze protein sulfenic acids. Mass Spectrom Rev. 2014 Mar-Apr; 33(2):126-46. PMID: 24105931.
      View in: PubMed
    27. Taneja NK, Ganguly T, Bakaletz LO, Nelson KJ, Dubey P, Poole LB, Deora R. D-alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing. J Bacteriol. 2013 Nov; 195(22):5102-11. PMID: 24013634.
      View in: PubMed
    28. Nelson KJ, Parsonage D, Karplus PA, Poole LB. Evaluating peroxiredoxin sensitivity toward inactivation by peroxide substrates. Methods Enzymol. 2013; 527:21-40. PMID: 23830624.
      View in: PubMed
    29. Michalek RD, Crump KE, Weant AE, Hiltbold EM, Juneau DG, Moon EY, Yu DY, Poole LB, Grayson JM. Peroxiredoxin II regulates effector and secondary memory CD8+ T cell responses. J Virol. 2012 Dec; 86(24):13629-41. PMID: 23055551.
      View in: PubMed
    30. Lang BS, Gorren AC, Oberdorfer G, Wenzl MV, Furdui CM, Poole LB, Mayer B, Gruber K. Vascular bioactivation of nitroglycerin by aldehyde dehydrogenase-2: reaction intermediates revealed by crystallography and mass spectrometry. J Biol Chem. 2012 Nov 02; 287(45):38124-34. PMID: 22988236.
      View in: PubMed
    31. Perkins A, Gretes MC, Nelson KJ, Poole LB, Karplus PA. Mapping the active site helix-to-strand conversion of CxxxxC peroxiredoxin Q enzymes. Biochemistry. 2012 Sep 25; 51(38):7638-50. PMID: 22928725.
      View in: PubMed
    32. Salsbury FR, Poole LB, Fetrow JS. Electrostatics of cysteine residues in proteins: parameterization and validation of a simple model. Proteins. 2012 Nov; 80(11):2583-91. PMID: 22777874.
      View in: PubMed
    33. Crump KE, Juneau DG, Poole LB, Haas KM, Grayson JM. The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol. 2012 Aug; 42(8):2152-64. PMID: 22674013.
      View in: PubMed
    34. Debnath A, Parsonage D, Andrade RM, He C, Cobo ER, Hirata K, Chen S, García-Rivera G, Orozco E, Martínez MB, Gunatilleke SS, Barrios AM, Arkin MR, Poole LB, McKerrow JH, Reed SL. A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat Med. 2012 Jun; 18(6):956-60. PMID: 22610278.
      View in: PubMed
    35. Salsbury FR, Yuan Y, Knaggs MH, Poole LB, Fetrow JS. Structural and electrostatic asymmetry at the active site in typical and atypical peroxiredoxin dimers. J Phys Chem B. 2012 Jun 14; 116(23):6832-43. PMID: 22401569.
      View in: PubMed
    36. Cho SH, Parsonage D, Thurston C, Dutton RJ, Poole LB, Collet JF, Beckwith J. A new family of membrane electron transporters and its substrates, including a new cell envelope peroxiredoxin, reveal a broadened reductive capacity of the oxidative bacterial cell envelope. MBio. 2012; 3(2). PMID: 22493033.
      View in: PubMed
    37. Qian J, Wani R, Klomsiri C, Poole LB, Tsang AW, Furdui CM. A simple and effective strategy for labeling cysteine sulfenic acid in proteins by utilization of ß-ketoesters as cleavable probes. Chem Commun (Camb). 2012 Apr 28; 48(34):4091-3. PMID: 22430672.
      View in: PubMed
    38. Karplus PA, Poole LB. Peroxiredoxins as molecular triage agents, sacrificing themselves to enhance cell survival during a peroxide attack. Mol Cell. 2012 Feb 10; 45(3):275-8. PMID: 22325349.
      View in: PubMed
    39. Gretes MC, Poole LB, Karplus PA. Peroxiredoxins in parasites. Antioxid Redox Signal. 2012 Aug 15; 17(4):608-33. PMID: 22098136.
      View in: PubMed
    40. Reeves SA, Parsonage D, Nelson KJ, Poole LB. Kinetic and thermodynamic features reveal that Escherichia coli BCP is an unusually versatile peroxiredoxin. Biochemistry. 2011 Oct 18; 50(41):8970-81. PMID: 21910476.
      View in: PubMed
    41. Poole LB, Hall A, Nelson KJ. Overview of peroxiredoxins in oxidant defense and redox regulation. Curr Protoc Toxicol. 2011 Aug; Chapter 7:Unit7.9. PMID: 21818754.
      View in: PubMed
    42. Kaplan N, Urao N, Furuta E, Kim SJ, Razvi M, Nakamura Y, McKinney RD, Poole LB, Fukai T, Ushio-Fukai M. Localized cysteine sulfenic acid formation by vascular endothelial growth factor: role in endothelial cell migration and angiogenesis. Free Radic Res. 2011 Oct; 45(10):1124-35. PMID: 21740309.
      View in: PubMed
    43. Qian J, Klomsiri C, Wright MW, King SB, Tsang AW, Poole LB, Furdui CM. Simple synthesis of 1,3-cyclopentanedione derived probes for labeling sulfenic acid proteins. Chem Commun (Camb). 2011 Aug 28; 47(32):9203-5. PMID: 21738918.
      View in: PubMed
    44. Wani R, Qian J, Yin L, Bechtold E, King SB, Poole LB, Paek E, Tsang AW, Furdui CM. Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc Natl Acad Sci U S A. 2011 Jun 28; 108(26):10550-5. PMID: 21670275.
      View in: PubMed
    45. Clarke TE, Romanov V, Chirgadze YN, Klomsiri C, Kisselman G, Wu-Brown J, Poole LB, Pai EF, Chirgadze NY. Crystal structure of alkyl hydroperoxidase D like protein PA0269 from Pseudomonas aeruginosa: homology of the AhpD-like structural family. BMC Struct Biol. 2011 May 26; 11:27. PMID: 21615954.
      View in: PubMed
    46. Nirudodhi S, Parsonage D, Karplus PA, Poole LB, Maier CS. Conformational studies of the robust 2-Cys peroxiredoxin Salmonella typhimurium AhpC by solution phase hydrogen/deuterium (H/D) exchange monitored by electrospray ionization mass spectrometry. Int J Mass Spectrom. 2011 Apr 30; 302(1-3):93-100. PMID: 21516234.
      View in: PubMed
    47. Hall A, Nelson K, Poole LB, Karplus PA. Structure-based insights into the catalytic power and conformational dexterity of peroxiredoxins. Antioxid Redox Signal. 2011 Aug 01; 15(3):795-815. PMID: 20969484.
      View in: PubMed
    48. Nelson KJ, Knutson ST, Soito L, Klomsiri C, Poole LB, Fetrow JS. Analysis of the peroxiredoxin family: using active-site structure and sequence information for global classification and residue analysis. Proteins. 2011 Mar; 79(3):947-64. PMID: 21287625.
      View in: PubMed
    49. Soito L, Williamson C, Knutson ST, Fetrow JS, Poole LB, Nelson KJ. PREX: PeroxiRedoxin classification indEX, a database of subfamily assignments across the diverse peroxiredoxin family. Nucleic Acids Res. 2011 Jan; 39(Database issue):D332-7. PMID: 21036863.
      View in: PubMed
    50. Saunders JA, Rogers LC, Klomsiri C, Poole LB, Daniel LW. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells. Free Radic Biol Med. 2010 Dec 15; 49(12):2058-67. PMID: 20934509.
      View in: PubMed
    51. Klomsiri C, Karplus PA, Poole LB. Cysteine-based redox switches in enzymes. Antioxid Redox Signal. 2011 Mar 15; 14(6):1065-77. PMID: 20799881.
      View in: PubMed
    52. Yuan Y, Knaggs M, Poole L, Fetrow J, Salsbury F. Conformational and oligomeric effects on the cysteine pK(a) of tryparedoxin peroxidase. J Biomol Struct Dyn. 2010 Aug; 28(1):51-70. PMID: 20476795.
      View in: PubMed
    53. Hall A, Parsonage D, Poole LB, Karplus PA. Structural evidence that peroxiredoxin catalytic power is based on transition-state stabilization. J Mol Biol. 2010 Sep 10; 402(1):194-209. PMID: 20643143.
      View in: PubMed
    54. Parsonage D, Reeves SA, Karplus PA, Poole LB. Engineering of fluorescent reporters into redox domains to monitor electron transfers. Methods Enzymol. 2010; 474:1-21. PMID: 20609901.
      View in: PubMed
    55. Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R, Poole LB, Fukai T, Ushio-Fukai M. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One. 2010 Apr 21; 5(4):e10189. PMID: 20422004.
      View in: PubMed
    56. Bechtold E, Reisz JA, Klomsiri C, Tsang AW, Wright MW, Poole LB, Furdui CM, King SB. Water-soluble triarylphosphines as biomarkers for protein S-nitrosation. ACS Chem Biol. 2010 Apr 16; 5(4):405-14. PMID: 20146502.
      View in: PubMed
    57. Parsonage D, Desrosiers DC, Hazlett KR, Sun Y, Nelson KJ, Cox DL, Radolf JD, Poole LB. Broad specificity AhpC-like peroxiredoxin and its thioredoxin reductant in the sparse antioxidant defense system of Treponema pallidum. Proc Natl Acad Sci U S A. 2010 Apr 06; 107(14):6240-5. PMID: 20304799.
      View in: PubMed
    58. Nelson KJ, Klomsiri C, Codreanu SG, Soito L, Liebler DC, Rogers LC, Daniel LW, Poole LB. Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins. Methods Enzymol. 2010; 473:95-115. PMID: 20513473.
      View in: PubMed
    59. Klomsiri C, Nelson KJ, Bechtold E, Soito L, Johnson LC, Lowther WT, Ryu SE, King SB, Furdui CM, Poole LB. Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteins. Methods Enzymol. 2010; 473:77-94. PMID: 20513472.
      View in: PubMed
    60. Hall A, Sankaran B, Poole LB, Karplus PA. Structural changes common to catalysis in the Tpx peroxiredoxin subfamily. J Mol Biol. 2009 Nov 06; 393(4):867-81. PMID: 19699750.
      View in: PubMed
    61. Hall A, Parsonage D, Horita D, Karplus PA, Poole LB, Barbar E. Redox-dependent dynamics of a dual thioredoxin fold protein: evolution of specialized folds. Biochemistry. 2009 Jun 30; 48(25):5984-93. PMID: 19459661.
      View in: PubMed
    62. Hall A, Karplus PA, Poole LB. Typical 2-Cys peroxiredoxins--structures, mechanisms and functions. FEBS J. 2009 May; 276(9):2469-77. PMID: 19476488.
      View in: PubMed
    63. Nelson KJ, Parsonage D, Hall A, Karplus PA, Poole LB. Cysteine pK(a) values for the bacterial peroxiredoxin AhpC. Biochemistry. 2008 Dec 02; 47(48):12860-8. PMID: 18986167.
      View in: PubMed
    64. Poole LB. Measurement of protein sulfenic acid content. Curr Protoc Toxicol. 2008 Nov; Chapter 17:Unit17.2. PMID: 20963754.
      View in: PubMed
    65. Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med. 2008 Oct 15; 45(8):1178-89. PMID: 18718523.
      View in: PubMed
    66. Poole LB, Nelson KJ. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol. 2008 Feb; 12(1):18-24. PMID: 18282483.
      View in: PubMed
    67. Salsbury FR, Knutson ST, Poole LB, Fetrow JS. Functional site profiling and electrostatic analysis of cysteines modifiable to cysteine sulfenic acid. Protein Sci. 2008 Feb; 17(2):299-312. PMID: 18227433.
      View in: PubMed
    68. Yamamoto Y, Ritz D, Planson AG, Jönsson TJ, Faulkner MJ, Boyd D, Beckwith J, Poole LB. Mutant AhpC peroxiredoxins suppress thiol-disulfide redox deficiencies and acquire deglutathionylating activity. Mol Cell. 2008 Jan 18; 29(1):36-45. PMID: 18206967.
      View in: PubMed
    69. Hutson SM, Poole LB, Coles S, Conway ME. Redox regulation and trapping sulfenic acid in the peroxide-sensitive human mitochondrial branched chain aminotransferase. Methods Mol Biol. 2008; 476:139-52. PMID: 19157014.
      View in: PubMed
    70. Parsonage D, Karplus PA, Poole LB. Substrate specificity and redox potential of AhpC, a bacterial peroxiredoxin. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8209-14. PMID: 18165315.
      View in: PubMed
    71. Nelson KJ, Day AE, Zeng BB, King SB, Poole LB. Isotope-coded, iodoacetamide-based reagent to determine individual cysteine pK(a) values by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem. 2008 Apr 15; 375(2):187-95. PMID: 18162165.
      View in: PubMed
    72. Poole LB, Klomsiri C, Knaggs SA, Furdui CM, Nelson KJ, Thomas MJ, Fetrow JS, Daniel LW, King SB. Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins. Bioconjug Chem. 2007 Nov-Dec; 18(6):2004-17. PMID: 18030992.
      View in: PubMed
    73. Michalek RD, Nelson KJ, Holbrook BC, Yi JS, Stridiron D, Daniel LW, Fetrow JS, King SB, Poole LB, Grayson JM. The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol. 2007 Nov 15; 179(10):6456-67. PMID: 17982034.
      View in: PubMed
    74. Jönsson TJ, Ellis HR, Poole LB. Cysteine reactivity and thiol-disulfide interchange pathways in AhpF and AhpC of the bacterial alkyl hydroperoxide reductase system. Biochemistry. 2007 May 15; 46(19):5709-21. PMID: 17441733.
      View in: PubMed
    75. Poole LB. The catalytic mechanism of peroxiredoxins. Subcell Biochem. 2007; 44:61-81. PMID: 18084890.
      View in: PubMed
    76. Phalen TJ, Weirather K, Deming PB, Anathy V, Howe AK, van der Vliet A, Jönsson TJ, Poole LB, Heintz NH. Oxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery. J Cell Biol. 2006 Dec 04; 175(5):779-89. PMID: 17145963.
      View in: PubMed
    77. Panmanee W, Vattanaviboon P, Poole LB, Mongkolsuk S. Novel organic hydroperoxide-sensing and responding mechanisms for OhrR, a major bacterial sensor and regulator of organic hydroperoxide stress. J Bacteriol. 2006 Feb; 188(4):1389-95. PMID: 16452421.
      View in: PubMed
    78. Poole LB, Zeng BB, Knaggs SA, Yakubu M, King SB. Synthesis of chemical probes to map sulfenic acid modifications on proteins. Bioconjug Chem. 2005 Nov-Dec; 16(6):1624-8. PMID: 16287263.
      View in: PubMed
    79. Roberts BR, Wood ZA, Jönsson TJ, Poole LB, Karplus PA. Oxidized and synchrotron cleaved structures of the disulfide redox center in the N-terminal domain of Salmonella typhimurium AhpF. Protein Sci. 2005 Sep; 14(9):2414-20. PMID: 16131664.
      View in: PubMed
    80. Parsonage D, Youngblood DS, Sarma GN, Wood ZA, Karplus PA, Poole LB. Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin. Biochemistry. 2005 Aug 09; 44(31):10583-92. PMID: 16060667.
      View in: PubMed
    81. Jönsson TJ, Murray MS, Johnson LC, Poole LB, Lowther WT. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. Biochemistry. 2005 Jun 21; 44(24):8634-42. PMID: 15952770.
      View in: PubMed
    82. Poole LB. Bacterial defenses against oxidants: mechanistic features of cysteine-based peroxidases and their flavoprotein reductases. Arch Biochem Biophys. 2005 Jan 01; 433(1):240-54. PMID: 15581580.
      View in: PubMed
    83. Conway ME, Poole LB, Hutson SM. Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme. Biochemistry. 2004 Jun 15; 43(23):7356-64. PMID: 15182179.
      View in: PubMed
    84. Poole LB. Formation and functions of protein sulfenic acids. Curr Protoc Toxicol. 2004 Feb; Chapter 17:Unit17.1. PMID: 20963761.
      View in: PubMed
    85. Poole LB, Karplus PA, Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol. 2004; 44:325-47. PMID: 14744249.
      View in: PubMed
    86. Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 2003 Apr 25; 300(5619):650-3. PMID: 12714747.
      View in: PubMed
    87. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. Human mitochondrial branched chain aminotransferase: structural basis for substrate specificity and role of redox active cysteines. Biochim Biophys Acta. 2003 Apr 11; 1647(1-2):61-5. PMID: 12686109.
      View in: PubMed
    88. Schröder E, Jönsson T, Poole L. Hydroxyapatite chromatography: altering the phosphate-dependent elution profile of protein as a function of pH. Anal Biochem. 2003 Feb 01; 313(1):176-8. PMID: 12576076.
      View in: PubMed
    89. Baker LM, Poole LB. Catalytic mechanism of thiol peroxidase from Escherichia coli. Sulfenic acid formation and overoxidation of essential CYS61. J Biol Chem. 2003 Mar 14; 278(11):9203-11. PMID: 12514184.
      View in: PubMed
    90. Wood ZA, Schröder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003 Jan; 28(1):32-40. PMID: 12517450.
      View in: PubMed
    91. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. Identification of a peroxide-sensitive redox switch at the CXXC motif in the human mitochondrial branched chain aminotransferase. Biochemistry. 2002 Jul 23; 41(29):9070-8. PMID: 12119021.
      View in: PubMed
    92. Yamamoto Y, Poole LB, Hantgan RR, Kamio Y. An iron-binding protein, Dpr, from Streptococcus mutans prevents iron-dependent hydroxyl radical formation in vitro. J Bacteriol. 2002 Jun; 184(11):2931-9. PMID: 12003933.
      View in: PubMed
    93. Wood ZA, Poole LB, Hantgan RR, Karplus PA. Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins. Biochemistry. 2002 Apr 30; 41(17):5493-504. PMID: 11969410.
      View in: PubMed
    94. Reynolds CM, Meyer J, Poole LB. An NADH-dependent bacterial thioredoxin reductase-like protein in conjunction with a glutaredoxin homologue form a unique peroxiredoxin (AhpC) reducing system in Clostridium pasteurianum. Biochemistry. 2002 Feb 12; 41(6):1990-2001. PMID: 11827546.
      View in: PubMed
    95. Poole LB, Ellis HR. Identification of cysteine sulfenic acid in AhpC of alkyl hydroperoxide reductase. Methods Enzymol. 2002; 348:122-36. PMID: 11885266.
      View in: PubMed
    Poole's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _